Treatment and prevention of cardiovascular events

Treatment and prevention of cardiovascular events

  • CN 1,822,820 A
  • Filed: 07/28/2004
  • Published: 08/23/2006
  • Est. Priority Date: 07/28/2003
  • Status: Active Application
First Claim
Patent Images

1. pharmaceutical dosage form is all included cholesterol reducing agent, rasied, and aspirin comprising the Beta-3 adrenergic receptor antagonist of therapeutic dose, diuretic or the two.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×